We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $81.9M
1-Year Est. Return 26.59%
This Fund
S&P 500
This Quarter Est. Return
+10.31%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$684M
AUM Growth
+$191M
Cap. Flow
+$175M
Cap. Flow %
25.54%
Top 10 Hldgs %
22.29%
Holding
1,116
New
453
Increased
148
Reduced
137
Closed
375

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$66.9M
2
TSLA icon
Tesla
TSLA
+$17M
3
SBUX icon
Starbucks
SBUX
+$7.73M
4
BABA icon
Alibaba
BABA
+$5.61M
5
FERG icon
Ferguson
FERG
+$5.09M

Top Sells

Rank Stock Value
1
MU icon
Micron Technology
MU
+$8.46M
2
UPS icon
United Parcel Service
UPS
+$6.5M
3
MDT icon
Medtronic
MDT
+$5.4M
4
PANW icon
Palo Alto Networks
PANW
+$5.27M
5
MMM icon
3M
MMM
+$4.22M

Sector Composition

Rank Sector Weight
1 Technology 18.5%
2 Consumer Discretionary 15.35%
3 Healthcare 11.88%
4 Financials 8.41%
5 Industrials 7.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
Z icon
176
Zillow
Z
$7.32B
$1.03M 0.15%
31,901
-13,000
-29% -$431K
KEYS icon
177
Keysight
KEYS
$53.6B
$1.02M 0.15%
5,944
+4,369
+277% +$745K
EQNR icon
178
Equinor
EQNR
$91.4B
$1.01M 0.15%
+28,307
New +$1.02M
FIVE icon
179
Five Below
FIVE
$11.5B
$1.01M 0.15%
5,700
+3,168
+125% +$498K
MNST icon
180
Monster Beverage
MNST
$93.2B
$1M 0.15%
+19,740
New +$956K
ALB icon
181
Albemarle
ALB
$13.7B
$1M 0.15%
+4,616
New +$1.23M
NLY icon
182
Annaly Capital Management
NLY
$16.9B
$989K 0.14%
+46,900
New +$923K
BLUE
183
DELISTED
bluebird bio
BLUE
$973K 0.14%
7,030
+1,050
+18% +$148K
XBI icon
184
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$971K 0.14%
11,703
-14,697
-56% -$1.19M
FANG icon
185
Diamondback Energy
FANG
$55.1B
$971K 0.14%
7,100
-12,200
-63% -$1.78M
UNM icon
186
Unum
UNM
$13.8B
$969K 0.14%
23,615
+17,400
+280% +$729K
K
187
DELISTED
Kellanova
K
$962K 0.14%
14,378
+8,052
+127% +$546K
AIG icon
188
American International
AIG
$42B
$961K 0.14%
+15,200
New +$884K
MEDP icon
189
Medpace
MEDP
$16.5B
$960K 0.14%
4,520
+2,700
+148% +$539K
WY icon
190
Weyerhaeuser
WY
$17.2B
$955K 0.14%
30,802
-5,800
-16% -$180K
PAAS icon
191
Pan American Silver
PAAS
$18.6B
$954K 0.14%
+58,358
New +$934K
GPN icon
192
Global Payments
GPN
$23B
$953K 0.14%
9,600
+1,300
+16% +$136K
NTNX icon
193
Nutanix
NTNX
$15.4B
$953K 0.14%
36,587
-5,900
-14% -$161K
DXCM icon
194
DexCom
DXCM
$28.3B
$952K 0.14%
+8,403
New +$923K
REXR icon
195
Rexford Industrial Realty
REXR
$8.63B
$942K 0.14%
+17,249
New +$930K
WMG icon
196
Warner Music
WMG
$14.4B
$942K 0.14%
+26,900
New +$784K
EXAS
197
DELISTED
Exact Sciences
EXAS
$942K 0.14%
19,025
+2,225
+13% +$90.9K
OKTA icon
198
Okta
OKTA
$23.9B
$934K 0.14%
+13,674
New +$781K
ARRY icon
199
Array Technologies
ARRY
$848M
$933K 0.14%
48,276
+1,800
+4% +$34.2K
FISV
200
Fiserv Inc
FISV
$27.9B
$932K 0.14%
+9,222
New +$918K

Similar funds

Bayesian Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Bayesian Capital Management held 1,116 positions worth $684M, up 39% from $493M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Bayesian Capital Management deployed $175M of net new capital in Q4 2022, opening 453 new positions and adding to 148 existing holdings. Its largest new stake was Tesla: 89,769 shares worth $11.1M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Medtronic, an estimated $5.4M trimmed.

  • Bayesian Capital Management's largest Q4 2022 buy was Tesla: 89,769 shares worth $11.1M.
  • Bayesian Capital Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2022, an estimated $66.9M increase.
  • Bayesian Capital Management's biggest Q4 2022 reduction was Medtronic, cutting an estimated $5.4M.
  • Bayesian Capital Management fully exited Micron Technology in Q4 2022, selling an estimated $8.46M.
  • Bayesian Capital Management's ten largest holdings make up 22% of its $684M portfolio in Q4 2022.
  • Bayesian Capital Management opened 453 new positions and closed 375 in Q4 2022.
  • Bayesian Capital Management's portfolio value rose 39% quarter-over-quarter to $684M.

Based on Bayesian Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.